Colgate-Palmolive (NYSE:CL) Shares Sold by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC reduced its position in Colgate-Palmolive (NYSE:CL) by 3.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,384 shares of the company’s stock after selling 356 shares during the period. SeaCrest Wealth Management LLC’s holdings in Colgate-Palmolive were worth $751,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Vest Financial LLC increased its holdings in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after acquiring an additional 74,337 shares in the last quarter. Central Bank & Trust Co. increased its holdings in Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after acquiring an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC increased its holdings in Colgate-Palmolive by 9.2% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after acquiring an additional 910 shares in the last quarter. Sarasin & Partners LLP increased its holdings in Colgate-Palmolive by 1.2% in the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after acquiring an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC increased its holdings in Colgate-Palmolive by 2.5% in the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after acquiring an additional 172 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the transaction, the executive vice president now owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The disclosure for this sale can be found here. Over the last quarter, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Trading Up 0.1 %

NYSE CL traded up $0.10 during trading hours on Friday, reaching $90.05. The company had a trading volume of 3,459,748 shares, compared to its average volume of 3,881,994. The stock has a 50-day moving average of $85.52 and a 200 day moving average of $79.06. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The stock has a market capitalization of $74.12 billion, a P/E ratio of 32.39, a price-to-earnings-growth ratio of 3.42 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the prior year, the company posted $0.77 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.9% compared to the same quarter last year. As a group, research analysts anticipate that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 71.94%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 target price for the company. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Finally, Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $87.31.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.